Company
Every investor coverage indicates participated in a round 4DMedical raised.
Companies 4DMedical acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Jordan Thurgood | Former Chief Innovation Officer (former) · Founder | Skalata Ventures (Tue 1 Sep 2026), Startup Daily, Skalata Ventures (undated) |
| Julian Sutton | Director (former) | Startup Daily (Wed 5 Aug 2026), Dealroom, Startup Daily (Thu 28 May 2026) |
Stories naming 4DMedical. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Skalata Ventures unveils its October 2021 seed intake of 13 startups, among them Ardacious and Strength By Numbers, and notes alumnus Preezie recently secured a $5.5 million Series A.
An AFR managed-funds topic page: a star small-caps deputy goes solo with a new Sydney firm, Gigacomm buys rival DGtek, Google plans a multibillion-dollar domestic bond, plus fund manager and market stories.
Melbourne biotech AlleSense, developing cancer pathology imaging tech, raised $5 million led by Welcome Ventures with Breakthrough Victoria and an AEA grant contributing.
Weekly roundup: eight funding rounds totalling $12.1m; Airwallex bought Leapfin; 4DMedical agreed a deal for Contextflow; Scalare Partners took over Fishburners; Airtree and Build Club each unveiled new founder programs.
Also Australian FinTech
La Trobe University spin-out AlleSense has secured $5 million to develop slide-based imaging for earlier cancer detection, led by Welcome Ventures with Breakthrough Victoria and the Australian Economic Accelerator's grant program also contributing.
Also Dealroom·Startup Daily
Weekly digest reporting Australia Post's purchase of delivery-software firm Rendr, an $83 million sharemarket raise by 4DMedical, Reserve Bank director Elana Rubin's move to Airwallex, and an Anthropic-government memorandum.
Also SmartCompany
Perennial's second pre-IPO fund has reached its full $125 million target and will soon deploy into healthcare, e-commerce and technology investments; its first trust backed Aroa Biosurgery, 4DMedical and Atomo Diagnostics, each now listed.
Relays an Australian Financial Review report that lung imaging company 4DMedical will list on the ASX at a $193 million market capitalisation, profiling founder Andreas Fouras and the technology's development.
Skalata's profile of portfolio company Strength by Numbers, whose AxIT hardware measures strength for health professionals, covering the four founders' backgrounds and the two investments Skalata made in 2021 and 2022.